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Abstract – The side effects of certain antibiotics have been a recent dilemma in the
medical arena. Due this fact, the necessity of natural product discovery could provide
important indications against several pharmacological targets and combat many infectious
agents. Piper arboreum Aub. (Piperaceae) has been used by Brazilian traditional commu-
nities against several illnesses including rheumatism, bronchitis, sexually transmitted dis-
eases and complaints of the urinary tract. Medicinal plants are a source of several remedies
used in clinical practice to combat microbial infections. In this study, ethanol extract and
fractions of Piper arboreum leaves were used to assay antimicrobial and modulatory
activity. The minimum inhibitory concentration (MIC) was determined using micro-
dilution method of ethanol extract and fractions from the leaves of P. arboreum ranging
between 8 and 1024 mg mL–1. The capacity of these natural products to enhance the activity
of antibiotic and antifungal drugs was also assayed. In these tests, natural products were
combined with drugs. The natural products assayed did not demonstrate any clinically
relevant antimicrobial activity (MIC ³ 1024 mg mL–1). However, the modulation of anti-
biotic activity assay observed a synergistic activity of natural products combined with
antifungal (such as nystatin and amphotericin B) and antibiotic drugs (such as amikacin,
gentamicin and kanamycin). According to these results, these natural products can be an
interesting alternative not only to combat infectious diseases caused by bacteria or fungi,
but also to combat enhanced resistance of microorganisms to antibiotic and antifungal
drugs.
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Introduction
The genus Piper (Piperaceae) presents almost 1,000 species, distributed mainly in the
tropical and subtropical regions of Asia and America. Plants from this genus are used for
commercial and medicinal purposes (NUNES et al. 2007) and demonstrate several biological
activities (RUIZ and ROQUE 2009). Antibacterial and trypanocidal activities have been
reported for Piper arboreum Aub. and this plant is used by traditional communities in Brazil
in the form of a decoct against rheumatism, bronchitis, and sexually transmitted diseases
(AGRA et al. 2007, RAMOS and KATO 2009, REGASINI et al. 2009).
The World Health Organization (WHO 1998) defines a medicinal plant as any plant that
contains any active compounds that can be used for therapeutic or chemical purposes.
Substances produced by plants are their defence mechanism against insects, herbivores, and
phytopathogenic microorganisms (GOTLIEB 1981). Some researchers have named these
phytocompounds »antibiotic like-substances« (GEISMANN 1963). The use of plant extracts
as antimicrobial agents represents a low risk for the development of resistance by the micro-
organisms because these products are composed of several phytocompounds of different groups
(DAFERERA et al. 2003).
Concerning resistance to antibiotics, many researchers have expressed their opinion that
natural products from plants could be interesting alternatives (DANCER 2001, NOSTRO et al.
2004, COUTINHO et al. 2005, GEORGOPAPADAKOU 2005). Several plant extracts and phyto-
chemicals are known for their antimicrobial properties. Many studies have been conducted
in different countries to demonstrate such activities (SALVAGNINI et al. 2008, SIMÕES et al.
2008, SILVA et al. 2008).
The Staphylococcus genus is found in skin and mucosal microbiota of animals and birds.
Some Staphylococcus species are etiological agents of many animal and human infections
(NOSTRO et al. 2004, COUTINHO et al. 2009a, b). Staphylococcus aureus, S. epidermidis, S.
saprophyticus and S. haemolyticus are the most important etiological agents of community
and nosocomial human infections. Besides, this bacterium is responsible for different types
of intoxications, being the most common etiological agent of infections on different tissues
and/or organs (e.g. furuncle, carbuncle, abscess, myocarditis, endocarditis, pneumonia,
meningitis, bacterial arthritis) (VERHOEFF et al. 1999). Escherichia coli is one of the most
important human infectious agents. This bacterium is an enterotoxin producer and the
causal agents of diarrhoea outbreaks (KONOWALCHUK et al. 1977, SCOTLAND et al. 1980) and
urinary tract infections (HUGHES et al. 1982).
Candidiasis is the most frequent mycosis caused by opportunistic fungi. The main species
associated with this disease are Candida albicans, C. tropicalis, C. parapsilosis, C. glabrata
and C. krusei (COUTINHO 2009). These yeasts are found in skin and in mucosal microbiota,
becoming pathogenic in patients with immunodeficiency or immunosuppression (DIGNANI
et al. 2003).
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Many plants have been evaluated not only for direct antimicrobial activity but also as
resistance-modifying agents (GIBBONS 2004). Several chemical compounds, synthetic or
from natural sources, have demonstrated a direct activity against many species of bacteria,
enhancing the activity of a specific antibiotic, reversing the natural resistance of bacteria to a
specific antibiotic, causing the elimination of plasmids and inhibiting the active efflux of
antibiotics through the plasma membrane (COUTINHO et al. 2009a, b). The potentiation of
antibiotic activity or the reversal of antibiotic resistance allows the classification of these
compounds as modifiers of antibiotic activity (COUTINHO et al. 2009a).
The aim of this work was to evaluate the antimicrobial and modulatory activity of
ethanol extract and fractions of Piper arboreum associated with antibiotic and antifungal
drugs against multiresistant bacteria and fungi.
Materials and methods
Microbial strains
The bacteria used in the minimum inhibitory concentration assay were the strains of E.
coli ATCC25923 and S. aureus ATCC10536. In the antifungal assays, the strains of
Candida albicans ATCC40006, C. krusei ATCC2538 and C. tropicalis ATCC40042 were
used. To evaluate the modulatory activity of the ethanol extract and fractions the multi-
resistant bacterial strains isolated from clinical environments: E. coli 27 and S. aureus 358
with the resistance profile were used (Tab. 1). All strains were obtained from the Laboratory
of Clinical Mycology – Universida de Federal da Paraíba.
Plant material
Stems of Piper arboreum were collected in March/2010 in the Gaiambira reserve,
Bananeiras County, Paraíba State (Brazil). The plant material was identified by Prof. Carlos
Alberto Garcia and a voucher (C. A. Garcia 205) was deposited in the Education and Health
Center Herbarium, Universida de Federal de Campina Grande. The leaves of Piper arbo-
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Tab. 1. Bacterial source and antibiotic resistance profile.
Bacteria Source Antibiotic resistance
Escherichia coli 27 Surgical wound
Ast, Ax, Ami, Amox, Ca, Cfc, Cf, Caz,
Cip, Clo, Im, Can, Szt, Tet, Tob
Escherichia coli ATCC10536 –
Staphylococcus aureus ATCC25923 –
Staphylococcus aureus 358 Surgical wound
Oxa, Gen, Tob, Ami, Can, Neo,
Para, But, Sis, Net
Ami – amicilina; Amox – amoxillin, Amp – ampicillin; Ast – aztreonam; Ax – amoxacillin; But –
butirosina; Ca – cefadroxil; Can – canamycin; Caz – ceftazinidima; Cfc – cefaclor; Cf – cephalothin;
Cip – ciprofloxacin; Clo – chloramphenicol; Com – cefepime; Ctz – ceftazidime; Gen – gentamicin;
Imi – imipenem; Lev – levofloxacin; Mer – merpenem; Neo – neomycin; Net – netilmicin; Oxa –
oxacillin; Sis – sisomicin; Szt – sulfametrim; Tet – tetracycline; Tob – tobramycin; Para – paramo-
micina; Ptz – piperacilina-tazobactam
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reum, after collection, were dried at 40 °C by 72 hours and powdered, obtaining 1.5 kg. The
powdered material was extracted by maceration using 1 L of 95% (v/v) methanol as solvent
at room temperature by three days, this process being repeated five times. The solution was
then filtered and concentrated under vacuum in a rotary evaporator under 60 °C and 760
mm/Hg of temperature and pressure, respectively. This amount of powdered material
yielded 350 g of ethanol extract.
The ethanol extract from the leaves (50 g) of Piper arboreum was dissolved in a mixture
of EtOH:H2O (7:3), generating a hydroalcohol solution which was submitted to a liquid/
liquid partition using the following solvents: hexane, dichloromethane and ethyl acetate.
The obtained solutions were mixed with sodium sulphate anhydrous (Na2SO4) and filtered.
After this process, the solutions were concentrated using a rotary vacuum evaporator at
temperatures below 50 °C, yielding the following fractions: hexane fraction (3 g), dichlo-
romethane fraction (3.5 g) and ethyl acetate fraction (9 g).
Drugs
The drugs used in the tests were the aminoglycosides kanamycin, amikacin, neomycin
and gentamicin, and the antifungals mebendazole, amphotericin B, nystatin and benzoyl-
metronidazole (Sigma Co., St. Louis, USA). All drugs were diluted in sterile water.
Minimum inhibitory concentration
The broth microdilution method was used in order to determine minimum inhibitory
concentration (MIC). The ethanol extract and fractions were dissolved using dimethyl-
sulfoxide and diluted to 1024 mg mL–1 using sterile distilled water. The bacterial inoculum
was diluted using brain heart infusion broth to a final concentration of 105 colony forming
units per mL. Each inoculum (100 mL) was distributed in each well of a microtiter 96 wells
plate and then submitted to a twofold serial dilution using 100 mL of the ethanol extract, with
concentrations ranging between 8 and 1024 mg mL–1. The plates were incubated for 24
hours at 35 °C (JAVADPOUR et al. 1996). Bacterial MIC was determined using resazurin, with
blue changing to red indicating bacterial growth. The fungal MIC was determined by
turbidity, observing the growth of fungal strains. The MIC was defined as the lowest
concentration in which no growth can be observed, according to CLSI (2008). Positive
controls of growth were performed using the culture medium with the microbial inoculum.
Drug modulation test
To observe how the ethanol extract and fractions affect the action of antimicrobial drugs
against the assayed strains, the method proposed by COUTINHO et al. (2008) was used. The
ethanol extracts and fractions were tested using a sub-inhibitory concentration (MIC/8 =
128 mg mL–1). A sample with 100 mL of the solution containing brain heart infusion broth,
the microbial inoculums and the extract or fractions was placed in each well. After this, 100
mL of the antimicrobial drug was mixed in the first well, following the twofold dilution.
Concentrations of aminoglycosides and antifungals ranged between 5000 and 2.44 mg mL–1
and 1024 and 2 mg mL–1, respectively. The assays were performed in triplicate.
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Results and discussion
The MIC results of the extract and fractions alone and combined with antifungals are
demonstrated in the table 2. Against all fungal strains assayed, the MIC observed was ³
1024 mg mL–1, these results not being clinically relevant. The same results were observed by
REGASINI et al. (2009). However, when the antifungal drugs were associated with the extract
and fractions, a synergistic activity was observed against C. krusei, enhancing the antifungal
drug activity. The MIC results of the natural products alone and combined with amino-
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Tab. 2. Minimum inhibitory concentration (MIC) of antifungal drugs alone and associated with extract
and fractions of Piper arboreum against C. albicans, C. krusei and C. tropicalis (mg mL–1).
DFPA C. albicans C. krusei C. tropicalis
Natural product/antifungal Alone + DFPA Alone + DFPA Alone + DFPA
DFPA ³ 1024 – ³ 1024 – ³ 1024 –
Amphotericin b ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
Mebendazole ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
Nystatin ³ 1024 ³ 1024 64 ³ 1024 ³ 1024 ³ 1024
Benzoilmetronidazole ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
EEPA
Natural product/antifungal Alone + EEPA Alone + EEPA Alone + EEPA
EEPA ³ 1024 – ³ 1024 – ³ 1024 –
Amphotericin b ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
Mebendazole ³ 1024 ³ 1024 ³ 1024 64 ³ 1024 ³ 1024
Nystatin ³ 1024 ³ 1024 64 64 ³ 1024 ³ 1024
Benzoilmetronidazole ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
HFPA
Natural product/antifungal Alone + HFPA Alone + HFPA Alone + HFPA
HFPA ³ 1024 – ³ 1024 – ³ 1024 –
Amphotericin b ³ 1024 ³ 1024 ³ 1024 2 ³ 1024 ³ 1024
Mebendazole ³ 1024 ³ 1024 ³ 1024 2 ³ 1024 ³ 1024
Nystatin ³ 1024 ³ 1024 64 1 ³ 1024 ³ 1024
Benzoilmetronidazole ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
EFPA
Natural product/antifungal Alone + EFPA Alone + EFPA Alone + EFPA
EFPA ³ 1024 – ³ 1024 – ³ 1024 –
Amphotericin b ³ 1024 ³ 1024 ³ 1024 2 ³ 1024 ³ 1024
Mebendazole ³ 1024 ³ 1024 ³ 1024 0.5 ³ 1024 ³ 1024
Nystatin ³ 1024 ³ 1024 64 64 ³ 1024 ³ 1024
Benzoilmetronidazole ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024 ³ 1024
DFPA – dichloromethane fraction; EEPA – ethanol extract from the leaves; HFPA – hexane fraction;
EFPA – ethyl acetate fraction
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glycosides are shown in the table 3. As observed with the antifungals, the natural products
also demonstrated a MIC ³ 1024 mg mL–1, but when the natural product was associated with
the aminoglycosides, a synergistic or antagonistic antibiotic activity was detected against
both bacterial strains assayed. When compared with the results of SUFFREDINI et al. (2006),
the results observed on this work indicate a better antibacterial activity.
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Tab. 3. Minimum inhibitory concentration (MIC) of antibiotics alone and associated with extract and
fractions of Piper arboreum against Escherichia coli strain 27 and Staphylococcus aureus
strain 358 (mg mL–1).
DFPA EC27 SA358
Natural product/antibiotic Alone + DFPA Alone + DFPA
DFPA ³ 1024 – ³ 1024 –
Kanamycin 1250 1250 156 39
Amikacin 2500 2500 78 78
78
Neomycin 1250 1250 78
Gentamicin 156 625 39 39
EEPA
Natural product/antibiotic Alone + EEPA Alone + EEPA
EEPA ³ 1024 – ³ 1024 –
Kanamycin 1250 1250 156 39
Amikacin 2500 625 78 78
Neomycin 1250 1250 78 78
Gentamicin 156 156 39 39
HFPA
Natural product/antibiotic Alone + HFPA Alone + HFPA
HFPA ³ 1024 – ³ 1024 –
Kanamycin 1250 ³ 5000 156 39
Amikacin 2500 78 78 78
Neomycin 1250 1250 78 78
Gentamicin 156 39 39 39
EFPA
Natural product/antibiotic Alone + EFPA Alone + EFPA
EFPA ³ 1024 – ³ 1024 –
Kanamycin 1250 1250 156 39
Amikacin 2500 312 78 78
Neomycin 1250 1250 78 78
Gentamicin 156 39 39 39
DFPA – dichloromethane fraction; EEPA – ethanol extract from the leaves; HFPA – hexane fraction;
EFPA – ethyl acetate fraction
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All these different MIC results can be attributed to the environmental conditions related
to the differences in the plants studied (CYSNE et al. 2005). However, the natural products of
P. arboreum enhanced the antimicrobial activity of the assayed drugs, acting in a synergistic
form (Tabs. 2, 3). This is the first report of synergism between natural products of P.
arboreum and antimicrobial agents.
There are several mechanisms involved in the inhibition of microorganism growth,
especially due to the hydrophobic nature of some phytocompounds. These compounds may
interact with the lipid bilayer of the cell membrane, affecting the respiratory chain and the
production of energy (WENDAKOON and SAKAGUCHI 1995) or enhancing the membrane
permeability, including permeability to antimicrobials (BURT 2004). This permeability
enhancement can be obtained from a combination of antimicrobial drugs with natural
products in a sub-inhibitory concentration (COUTINHO et al. 2008, 2009b).
This strategy refers the usage of natural products and drugs in an approach with mono-
or multi-extract combinations that will affect not only a single but several targets (HEMAIS-
WARYA et al. 2008, WAGNER et al. 2009).
Conclusions
As demonstrated in our work, natural products of Piper arboreum showed an expressive
capacity to modulate the activity of antimicrobial drugs in a synergistic or antagonistic
manner, representing an alternative to the efforts to control infectious diseases caused by
multidrug-resistant strains of fungi and bacteria.
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